CIK 0001807120
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Design Therapeutics, Inc.
Sign in to watch- Ticker
- DSGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823929248
- Phone
- +1 858-293-4900
- Business address
- 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 7,450 shares at an average $8.39 ($62,503)
- 4 Open-market buy Director bought 900,000 shares at an average $8.42 ($7,574,078)
- 4 Open-market buy 10% owner bought 900,000 shares at an average $8.42 ($7,574,078)
- 4 Open-market buy Director bought 15,000 shares at $7.96 ($119,426)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 25,000 shares at $18.99 ($474,680)
- 4 Open-market sale Director sold 590,880 shares at an average $19.07 ($11,266,197)
- 4 Other acquisition Director acquired 11,806 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 6 · 117 filings